Clinical trial
Estrogen, HDL, and Coronary Heart Disease in Women
NCT00083824 · Tufts University, Other · Completed
Key facts
| NCT number | NCT00083824 |
|---|---|
| Title | Estrogen, HDL, and Coronary Heart Disease in Women |
| Official title | Estrogen, HDL, and Coronary Heart Disease in Women |
| Lead sponsor | Tufts University, Other |
| Collaborators | National Heart, Lung, and Blood Institute (NHLBI) NIH |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Cardiovascular Diseases, Coronary Disease, Heart Diseases, Coronary Arteriosclerosis |
| Intervention type | Drug |
| Interventions | Estrogens, Conjugated (USP), Medroxyprogesterone 17-Acetate, Placebo |
| Enrollment | 309 |
| Start date | Mar 1, 2004 |
| Primary completion | Feb 1, 2007 |
| Completion | Feb 1, 2007 |
| First posted | Jun 4, 2004 |
| Last update posted | Apr 21, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: